The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

EditCo Bio, a leader in cutting-edge genetic engineering and cellular model solutions, today announced the launch of XDel Knockout Cells, an innovative product designed to revolutionize the field of ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

The UK is poised to lead the next great leap in agriculture, with gene-editing technology offering a lifeline to a ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...